Abstract:Free Fatty Acid Receptor 4 (FFAR4), a G-protein-coupled receptor, is responsible for triggering intracellular signaling pathways that regulate various physiological processes. FFAR4 agonists are associated with enhancing insulin release and mitigating the atherogenic, obesogenic, pro-carcinogenic, and pro-diabetogenic effects, normally associated with the free fatty acids bound to FFAR4. In this research, molecular structure-based machine-learning techniques were employed to evaluate compounds as potential agonists for FFAR4. Molecular structures were encoded into bit arrays, serving as molecular fingerprints, which were subsequently analyzed using the Bayesian network algorithm to identify patterns for screening the data. The shortlisted hits obtained via machine learning protocols were further validated by Molecular Docking and via ADME and Toxicity predictions. The shortlisted compounds were then subjected to MD Simulations of the membrane-bound FFAR4-ligand complexes for 100 ns each. Molecular analyses, encompassing binding interactions, RMSD, RMSF, RoG, PCA, and FEL, were conducted to scrutinize the protein–ligand complexes at the inter-atomic level. The analyses revealed significant interactions of the shortlisted compounds with the crucial residues of FFAR4 previously documented. FFAR4 as part of the complexes demonstrated consistent RMSDs, ranging from 3.57 to 3.64, with minimal residue fluctuations 5.27 to 6.03 nm, suggesting stable complexes. The gyration values fluctuated between 22.8 to 23.5 nm, indicating structural compactness and orderliness across the studied systems. Additionally, distinct conformational motions were observed in each complex, with energy contours shifting to broader energy basins throughout the simulation, suggesting thermodynamically stable protein–ligand complexes. The two compounds CHEMBL2012662 and CHEMBL64616 are presented as potential FFAR4 agonists, based on these insights and in-depth analyses. Collectively, these findings advance our comprehension of FFAR4's functions and mechanisms, highlighting these compounds as potential FFAR4 agonists worthy of further exploration as innovative treatments for metabolic and immune-related conditions.

Structural insights into endogenous ligand selectivity and activation mechanisms of FFAR1 and FFAR2

Machine learning- and structure-based discovery of a novel chemotype as FXR agonists for potential treatment of nonalcoholic fatty liver disease

Structural Insights into Ligand Recognition and Activation of Angiotensin Receptors.

Molecular Insights into Ago-Allosteric Modulation of the Human Glucagon-Like Peptide-1 Receptor

Molecular recognition and activation mechanism of short-chain fatty acid receptors FFAR2/3

Structural insights into ligand recognition and activation of the medium-chain fatty acid-sensing receptor GPR84

Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2

Structural basis of omega-3 fatty acid receptor FFAR4 activation and G protein coupling selectivity

Addressing free fatty acid receptor 1 (FFAR1) activation using supervised molecular dynamics

Orthosteric ligand selectivity and allosteric probe dependence at Hydroxycarboxylic acid receptor HCAR2

Distinct binding hotspots for natural and synthetic agonists of FFA4 from in silico approaches

Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2

Structural basis for the ligand recognition and signaling of free fatty acid receptors

Structural insights into ligand recognition, activation, and signaling of the α 2A adrenergic receptor

Predicting FFAR4 agonists using structure-based machine learning approach based on molecular fingerprints

Molecular Insights into Ligand Recognition and Activation of Chemokine Receptors CCR2 and CCR3

Unveiling the structural mechanisms of nonpeptide ligand recognition and activation in human chemokine receptor CCR8

Cryo-EM structures of adenosine receptor A3AR bound to selective agonists

Discovery of Novel Receptors for Lipid Mediators - a study leading to the identification of receptors involved in metabolism and the immune system

Asymmetric binding of coactivator SRC1 to FXR-RXR and allosteric communication within the complex

Structural insights into ligand recognition and selectivity of the human hydroxycarboxylic acid receptor HCAR2